OPD follow up 1. General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2.

Slides:



Advertisements
Similar presentations
Proteinuria and Haematuria – an update Alex Heaton
Advertisements

1 Type 1 Diabetes Mellitus Treatment. 2 Goals of T1DM Management Utilize intensive therapy aimed at near-normal BG and A1C levels Prevent diabetic ketoacidosis.
PROTEINURIA AND HEMATURIA ASHIK HAYAT M.D.. Proteinuria and Nephrotic Syndrome Occurrence of proteinuria in a single urine is relatively common. Will.
Eric Sherman Pediatric Endo Fellow Captain, USAF, MC
Diabetes and Hypothyroidism
Nephrotic Syndrome in Children Laura Cornish GPST2 Airedale VTS
Diabetes Care Summary of Revisions for the 2014 Clinical Practice Recommendations Copied from:
DIABETES AND THE KIDNEYS
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Diabetes Claire Nowlan Nov 28, Comparison of type 1 and 2 diabetes Type 1 10% of diabetics Age of onset – young Severe Requires insulin Normal build.
Chronic Care Plan. Programme 1 2 Long-term complications Co-morbid conditions.
Diabetes Mellitus.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Lecture 9.  Presence of excess of serum proteins in the urine is called proteinuria.  The excess of protein leads to foamy or frothy urine  Up to 150.
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
Continuity Clinic Proteinuria. Continuity Clinic.
1 Diabetes Education Teaching Guide Kidney Health.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
1. DIABETIC NEPHROPATHY Dr. Shahrzad Shahidi 2 CLASSIFICATION 1. Type 1 (due to b-cell destruction, usually leading to absolute insulin deficiency) 2.
DIABETES MELLITUS DR. J. PRATHEEBA DEVI. Definition Definition Diabetes is a metabolic disorder characterized by raised levels of glucose in the blood.
Monitoring Renal Transplants Planning follow up based on risks & cost.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Adult Medical-Surgical Nursing
Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.
Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University
Nursing Care of Clients with Diabetes Mellitus.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
DIABETIC ATHLETES Sports Injury Management. There are two types of diabetes. Type I: deficiency of insulin Type I is treated with insulin (injections,
Diabetes and Kidney. Diabetic Kidney Normal Kidney.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
Assessing the patient Exercise and Type 1 Diabetes 2nd National conference NEC, 15 May 2015.
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Summary of Revisions for the 2013 Clinical Practice Recommendations Copied from:
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Estimation of blood glucose in diabetes mellitus.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Complications Acute and Chronic. Complications  Acute: sudden onset usually reversible  Chronic: gradual onset can be irreversible.
Diabetic Nephropathy in the Adolescent Age Group Henry Rodriguez, M.D. Associate Professor of Pediatrics Indiana University School of Medicine Director,
Diabetic Nephropathy. Outline  Introduction of diabetic nephropathy  Manifestations of diabetic nephropathy  Staging of diabetic nephropathy  Microalbuminuria.
DIABETES MELLITUS IN CHILDREN. Blood glucose Apart from transient illness-induced or stress-induced hyperglycemia, a random whole-blood glucose.
PREVELANCE OF COMPLICATIONS OF DIABETES MELLITUS IN EGYPT Prof Morsi Arab University of Alexandria.
diabetes Prior classification of diabetes 1.Diabetes mellitus a. type1-insullin-dependent diabetes mellitus b. type2-noninsullin- dependent diabetes mellitus.
Section IV. Routine and Optional Laboratory Tests for the Investigation of Patients with Hypertension 2015 Canadian Hypertension Education Program Recommendations.
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
DIABETIC TEACHING VERMALYNPAULETTEMICHELLEEDWARD.
DIABETES by PAULINE ANSINE BSN. RN. WHAT IS DIABETES Diabetes is a serious lifelong condition that cannot be cured, but can be managed. With diabetes,
PROTEINURIA DR HEDAYATI. INTRODUCTION  URINARY PROTEIN > 150mg/day  More than 1 time  ↑ capillary permeability.
JULY 8 TH 2010 Good Morning!. Risk Factors Obesity Positive Family History Specific Ethnic Groups Gender Conditions with Insulin Resistance  Puberty.
Dr.Ruba Nashawati. Diabetes  Leading cause of ESRD  30% 40%  DN  DN Risk type I = type II.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
Background notes Audience: diabetes professional (entry level), patients with diabetes First slide: ADD your name/institution ‘Sponge bob’ slide: hemoglobin.
What is Diabetes? Definition: A disorder of metabolism where the pancreas produces little or no insulin or the cells do not respond to the insulin produced.
Chronic Care Plan.
Diabetes mellitus.
III. Endocrine Pancreas Diabetes Mellitus
Diabetic hypoglycemia from prevention to management.
Estimation of blood glucose in diabetes mellitus
Diabetes Mellitus Nursing Management.
Care of Patients with Diabetes Mellitus
Endocrine and Metabolic Systems
Metabolic Changes in Diabetes Mellitus
Jessica johnson, pharm. D.
Diabetes Health Status Report
Hypertension evaluation
Chapter 26 Endocrine Function
Key Insulin Side Effects*
Chronic Care Plan.
Presentation transcript:

OPD follow up 1

General P/E Blood pressure Sites of insulin injection Deep tendon reflex 2

Physical examination Height and weight : Poor glycemic control Hypothyroidism Celiac 3

Blood pressure Physical examination 4

Pubertal assessment— puberty increases insulin resistance Thyroid — Check for thyroid enlargement Physical examination 5

Skin — Examination of injection sites for evidences of lipohypertrophy or atrophy Physical examination 6

Extremities — for evidence of limited joint mobility or peripheral neuropathy Annual foot examination in children ≥10 years of age Physical examination 7

 Eye Exam Time for screening? Before puberty :after 5 years of DM onset. After puberty:after 2 years of DM onset. Thereafter Annual ophthalmologic evaluation is needed. Physical examination 8

Laboratory evaluation  Hb A1C : every three months 9

 Age-specific goals for A1C are: <6 years of age: < % to 12 years of age: < % 8 13 to 19 years of age: < % 7.5 Over 19 years of age: < % 7.0  Age-specific goals for A1C are: <6 years of age: < % to 12 years of age: < % 8 13 to 19 years of age: < % 7.5 Over 19 years of age: < % 7.0 Laboratory evaluation 10

 Thyroid screening All children with type 1 diabetes should be screened regularly for thyroid disease at diagnosis and then every one to 2 year. Laboratory evaluation 11

 The best time for testing Several weeks after the diagnosis of type 1 diabetes( when metabolic control has been established) Laboratory evaluation 12

 Lab testing TSH Anti TPO & Anti TG Ab Laboratory evaluation 13

 If Abs are positive Patient should be monitored closely(6 mo). Repeat antibody testing is not needed. Laboratory evaluation 14

 Celiac screening All children with type 1 diabetes should be screened for celiac disease at diagnosis. Laboratory evaluation 15

 Best time for screening Soon after the diagnosis of type 1 diabetes Laboratory evaluation 16

 Best test ANTI TTG If the screening test is negative: rescreen every other year. Total IgA Laboratory evaluation 17

 Nephropathy screening The best time for screening? Before puberty :after 5 years of DM onset After puberty:after 2 years of DM onset There after Annual evaluation is needed. Laboratory evaluation 18

 Lab evaluation Random urine sample : microalbumin to creatinine ratio Laboratory evaluation 19

 Microalbuminuria A value of microalbumin to creatinine ratio ≥ 30 mg/g or μg/mg. Diagnosis of microalbuminuria requires an elevation in albumin excretion that persists over a three- to six-month period. Laboratory evaluation 20

 False positive test Urinary tract infection Hematuria Acute febrile illness Vigorous exercise Short-term pronounced hyperglycemia Uncontrolled hypertension Heart failure 21

Microalbuminuria and diabetic nephropathy The urine dipstick is a relatively insensitive marker for initial increases in protein excretion, not becoming positive until protein excretion exceeds 300 to 500 mg/day. 22

Microalb ; 40 mg/lit Urine creat ; 50 mg/dl Ratio : 40 × 1000 / 50 × 10 = 80 23

Monitoring of DM Lipid profile — Screen for dyslipidemia once puberty begins, and if normal, repeat the screen every five years. If abnormal, screen yearly. rescreening at the time of a prolonged episode of poor glycemic control. 24

 Screening for dyslipidemia After 2 years old ( after diagnosis) If the profile is within the accepted risk levels it should be repeated every five years. Because of poor control in our children we check lipid profile annaully. Laboratory evaluation 25

 Goal lipid levels LDL <100 mg/dl HDL >35 mg/dl TG <150 mg/dl 26

GLYCEMIC CONTROL Age-specific ADA blood glucose goals are: Bedtime - <6 years of age: 110 to 200 mg/dL - 6 to 12 years of age: 100 to 180 mg/dL - 13 to 19 years of age: 90 to 150 mg/dL 27

GLYCEMIC CONTROL Before meals - <6 years of age: 100 to 180 mg/dL - 6 to 12 years of age: 90 to 180 mg/dL - 13 to 19 years of age: 90 to 130 mg/dL 28

Monitoring of DM A1C, every three months. Celiac disease screening at diagnosis and every other year. Thyroid function testing —every one or two years. 29

Monitoring of DM Annual screening for microalbuminuria for children ≥10 years of age and five-year duration of diabetes Annual ophthalmologic examination for children ≥10 years of age and three- to five-year duration of diabetes — Screen for retinopathy Annual foot examination — Evaluate foot health and screen for neuropathy in children ≥10 years of age 30

Microalbuminuria and diabetic nephropathy Increased urinary protein excretion is the earliest clinical finding of diabetic nephropathy. 31

Microalbuminuria and diabetic nephropathy Persistent albumin excretion between 30 and 300 mg/day (20 to 200 µg/min) is called microalbuminuria Values above 300 mg/day (200 µg/min) are considered to represent overt proteinuria 32

Microalbuminuria and diabetic nephropathy Fever, exercise, heart failure, and poor glycemic control,HTN are among the factors that can cause transient microalbuminuria. 33

Microalbuminuria and diabetic nephropathy 24-hour urine collection was previously the gold standard for the detection of microalbuminuria. screening can be more simply achieved by a timed urine collection or an early morning specimen to minimize changes in urine volume that occur during the day. 34

Albumin-to-creatinine ratio A value above 30 mg/g (or 0.03 mg/mg) suggests that albumin excretion is above 30 mg/day and therefore that microalbuminuria is probably present. 35

Hypoglycemic reaction 36

Symptoms & signs :  Pallor  Cold sweating  Palpitation  Tachycardia  Hunger  haedache 37

Symptoms & signs :  Nervousness  Nightmare  Cerebral glucopenia  Convulsion  LOC 38

Etiology : Technical No feeding Activity Insulin Ab Adrenal insufficiency Celiac disease 39

Etiology : Hypothyroidism Lipodystrophy Renal failure Somogyi phenomenon Honeymoon period Hypoglycemia unawareness 40

Treatment of hypoglycemia :  Glucose 5 – 10 gr po  Glucagon 0.5 – 1 mg im 41